NLRP3 and metabolic disease: Our results, for the first time, demonstrate a novel direct action of endothelial Nlrp3 inflammasome on the development of endothelial dysfunction and injury during the early stage of metabolic disorders such as obesity or high‐fat/cholesterol diet.